+44 (0) 1223 755950
+1 832 327 7413
Click on the image to see the image legend
Target | Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Spike Protein RBD (KP.2 Variant) |
Target Modification | Ile332Val, Gly339His, Lys356Thr, Ser371Phe, Ser373Pro, Ser375Phe, Thr376Ala, Arg403Lys, Asp405Asn, Arg408Ser, Lys417Asn, Asn440Lys, Val445His, Gly446Ser, Asn450Asp, Leu452W, Leu455Ser, Asn460Lys, Ser477Asn, Thr478Lys, Asn481Lys, Val482del, Glu484Lys, Phe486Pro, Gln498Arg, Asn501Tyr, Tyr505His |
Modification | Mutation |
Origin | Virus |
Expression | Recombinant |
Tested Applications | ELISA, WB, SDS-PAGE |
Host | Mammalian cells |
Recommended dilutions | Optimal dilutions/concentrations should be determined by the end user. |
Conjugation | Unconjugated |
Form | Lyophilized |
Purity | > 90% (SDS-PAGE) |
Reconstitution | Reconstitute in ddH2O. |
Storage | Store between -20 °C and -80 °C. Avoid repeated freeze/thaw cycles. |
UniProt Primary AC | P0DTC2 (UniProt, ExPASy) |
Molecular Weight | Calculated MW: 27.68 kDa |
Sequence Fragment | Arg316-Lys533 |
Tag | C-terminal His tag |
Buffer | Prior to lyophilization: PBS, pH 7.4 containing 1 mM EDTA, 4% Trehalose, 1% Mannitol. |
Availability | Shipped within 5-10 working days. |
Note | This product is for research use only. Not for human consumption, cosmetic, therapeutic or diagnostic use. |